Register free for our breaking news email alerts with analysis and cutting edge commentary from our award winning team. Registration only takes a minute.
Showing fund managers & funds available in United Kingdom. View fund & fund manager rankings globally
5 Comments Woodford Patient Capital plunges as Prothena trial fails

Woodford Patient Capital plunges as Prothena trial fails

Prothena, one of the big biotech bets of fund manager Neil Woodford, has failed a key drugs test, wiping two thirds from its market value and souring third anniversary of his Woodford Patient Capital Trust.

Funds & Fund Managers

All calculations in GBP, unless stated
over :
 Average Manager Total Return : 0.7% (31 March 2017 - 31 March 2018)
Total Return
1 of 104

16.0%

2 of 104

12.0%

3 of 104

10.4%

3 of 104

10.4%

5 of 104

8.8%

6 of 104

7.1%

7 of 104

6.9%

7 of 104

6.9%

9 of 104

6.1%

9 of 104

6.1%

11 of 104

5.6%

12 of 104

5.4%

13 of 104

4.9%

14 of 104

4.6%

15 of 104

4.5%

15 of 104

4.5%

17 of 104

4.4%

18 of 104

4.4%

19 of 104

4.2%

19 of 104

4.2%

21 of 104

4.1%

22 of 104

4.0%

23 of 104

3.9%

24 of 104

3.9%

25 of 104

3.9%

26 of 104

3.5%

27 of 104

3.3%

28 of 104

3.0%

29 of 104

2.9%

29 of 104

2.9%

31 of 104

2.9%

31 of 104

2.9%

31 of 104

2.9%

31 of 104

2.9%

35 of 104

2.8%

36 of 104

2.3%

37 of 104

1.8%

37 of 104

1.8%

39 of 104

1.6%

40 of 104

1.5%

40 of 104

1.5%

40 of 104

1.5%

43 of 104

1.4%

44 of 104

1.3%

45 of 104

1.3%

46 of 104

1.1%

47 of 104

0.9%

48 of 104

0.9%

48 of 104

0.9%

48 of 104

0.9%

51 of 104

0.9%

52 of 104

0.5%

53 of 104

0.3%

54 of 104

0.0%

54 of 104

0.0%

54 of 104

0.0%

57 of 104

-0.2%

58 of 104

-0.3%

59 of 104

-0.5%

59 of 104

-0.5%

61 of 104

-0.6%

61 of 104

-0.6%

63 of 104

-0.7%

64 of 104

-0.8%

64 of 104

-0.8%

66 of 104

-0.9%

67 of 104

-1.0%

68 of 104

-1.2%

68 of 104

-1.2%

70 of 104

-1.2%

71 of 104

-1.2%

72 of 104

-1.3%

73 of 104

-1.4%

74 of 104

-1.4%

74 of 104

-1.4%

76 of 104

-1.4%

77 of 104

-1.5%

78 of 104

-1.6%

78 of 104

-1.6%

80 of 104

-1.6%

81 of 104

-1.6%

81 of 104

-1.6%

83 of 104

-1.7%

84 of 104

-1.9%

85 of 104

-2.4%

85 of 104

-2.4%

87 of 104

-2.4%

88 of 104

-3.0%

89 of 104

-3.1%

90 of 104

-3.3%

91 of 104

-3.6%

92 of 104

-3.9%

93 of 104

-4.8%

94 of 104

-4.9%

95 of 104

-5.0%

96 of 104

-5.4%

97 of 104

-5.5%

98 of 104

-6.2%

99 of 104

-7.1%

100 of 104

-7.3%

100 of 104

-7.3%

102 of 104

-7.4%

103 of 104

-12.4%

104 of 104

-13.8%

Managers with less than 12 months history are below. View 1 month performance
Show more managers
Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated). Portions of the information contained on this page was derived by Citywire Financial Publishers Ltd using content supplied by Lipper, A Reuters Company.

Aberdeen Standard equity restructure sees six fund managers exit

The restructure follows the mega-merger between Standard Life and Aberdeen Asset Management last year.

Brewin cuts extra costs as it hits halfway point in MPS overhaul

The wealth firms has unveiled extra savings after transferring £750 million worth of MPS assets into its new manager-of-manager funds.

Aberdeen Standard Investments sues Provident Financial

Aberdeen Standard Investments has launched legal action against Provident Financial, claiming the firm was not transparent over a regulatory investigation into its credit card subsidiary.

Woodford's flagship fund ejected from Equity Income sector

The £6.8 billion Woodford Equity Income fund has been booted from the IA's equity income sector after failing to meet yield requirements.

FTSE falls as China reignites global trade war fears

Reports China is preparing to retaliate against US president Donald Trump's tariff plans weighs on stock markets.

Burford bounce boosts Woodford and Barnett

Shares in litigation finance provider surge, providing some relief to major fund manager backers Neil Woodford and Mark Barnett.

Woodford sells £40m AJ Bell stake to Invesco Perpetual

Woodford Investment Management sold his 8% AJ Bell stake to his former employers shortly before the firm unveiled its IPO plan.

Evenlode to soft close A-rated Yarrow's £2bn income fund

Evenlode is to soft close the fund after a surge in assets over the last year

Woodford buys more Provident as shares surge

Fund manager buys more shares in doorstep lender as shares soar on smaller-than-feared rights issue and FCA settlement.

Provident soars on relief over redress and rights issue

Shares in doorstep lender surge 73% as settlement with regulator and capital raise are both smaller than feared.

Read More